Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Phase I study of everolimus plus weekly paclitaxel and trastuzumab in patients with metastatic breast cancer pretreated with trastuzumab.

Andre F, Campone M, O'Regan R, Manlius C, Massacesi C, Sahmoud T, Mukhopadhyay P, Soria JC, Naughton M, Hurvitz SA.

J Clin Oncol. 2010 Dec 1;28(34):5110-5. doi: 10.1200/JCO.2009.27.8549. Epub 2010 Oct 25.

PMID:
20975068
2.

A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2.

C├ębe Suarez S, Pieren M, Cariolato L, Arn S, Hoffmann U, Bogucki A, Manlius C, Wood J, Ballmer-Hofer K.

Cell Mol Life Sci. 2006 Sep;63(17):2067-77.

PMID:
16909199
3.

Induction of TNF-alpha autoantibody production by AutoVac TNF106: a novel therapeutic approach for the treatment of allergic diseases.

Zuany-Amorim C, Manlius C, Dalum I, Jensen MR, Gautam A, Pay G, Mouritsen S, Walker C.

Int Arch Allergy Immunol. 2004 Feb;133(2):154-63. Epub 2004 Jan 26.

PMID:
14745228
4.

Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720.

Sawicka E, Zuany-Amorim C, Manlius C, Trifilieff A, Brinkmann V, Kemeny DM, Walker C.

J Immunol. 2003 Dec 1;171(11):6206-14.

5.

Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation.

Zuany-Amorim C, Manlius C, Trifilieff A, Brunet LR, Rook G, Bowen G, Pay G, Walker C.

J Immunol. 2002 Aug 1;169(3):1492-9.

6.

Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells.

Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C.

Nat Med. 2002 Jun;8(6):625-9.

PMID:
12042815

Supplemental Content

Loading ...
Support Center